ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

Bayh To Receive ACCC Annual Award

February 8, 1980

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

Minority Demonstration Centers Concept

May 12, 1989

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

Peter Shields Named Deputy Director At Ohio State

September 16, 2011